← FDA Drug Approvals (Drugs@FDA)

CARMUSTINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2018-09-11

Drug application

FDA Application #

ANDA210179

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARMUSTINE

Generic name

CARMUSTINE

Active ingredients

CARMUSTINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

NAVINTA LLC

Manufacturer

Zydus Pharmaceuticals USA Inc.

First approval

2018-09-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown